BOSTON--(BUSINESS WIRE)--Jan. 7, 2019--
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the
Company will report its financial results for the fourth quarter and
full year ended December 31, 2018 before the US financial markets open
on February 4, 2019. Following the release of the financial results,
Alexion management will conduct a conference call and audio webcast at
8:00 a.m. Eastern Time (ET).
To participate in this conference call, dial 866-762-3111 (USA) or
210-874-7712 (International), conference ID 5972194 shortly before 8:00
a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com
and an archived version will be available for a limited time following
View source version on businesswire.com: https://www.businesswire.com/news/home/20190107005228/en/
Source: Alexion Pharmaceuticals, Inc.
Susan Altschuller, Ph.D.
Vice President, Investor